Skip to Content

Join the 'Irinotecan Liposomal' group to help and get support from people like you.

Irinotecan Liposomal News

Cancer Drugs' High Prices Not Justified by Cost of Development, Study Contends

Posted 12 Sep 2017 by

TUESDAY, Sept. 12, 2017 – Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs. But a new analysis, focused on 10 new cancer drugs, finds those costs may have been greatly exaggerated – and the return on investment for drug companies is lucrative indeed. The study found that the typical R&D process for a ...

Publicly Funded Cancer Trials Gained Americans 3 Million More Years

Posted 6 Jun 2017 by

TUESDAY, June 6, 2017 – Public-funded trials have significantly extended the lives of people diagnosed with cancer, according to new research. SWOG, the clinical trials network funded by the U.S. National Cancer Institute (NCI), has involved more than 200,000 patient volunteers. These trials have led to approval of 14 new cancer drugs and more than 100 changes to cancer care standards. All told, ...

U.S. Pays Highest Prices for Cancer Meds: Study

Posted 6 Jun 2016 by

MONDAY, June 6, 2016 – The United States pays the highest prices in the world for generic and brand-name cancer drugs, a new study has found. However, as the world's wealthiest nation, the United States is better able to pay for those pricey drugs than poorer countries with somewhat lower medication prices, added study lead author Dr. Daniel Goldstein. People in China and India are much less ...

'Precision' Cancer Treatment May Extend Lives

Posted 20 May 2016 by

THURSDAY, May 19, 2016 – "Precision" cancer treatment that's guided by genetic clues from the patient's own tumor appears to outperform traditional chemotherapy, a new research review finds. Patients given precision – or personalized – treatment experienced a tumor shrinkage rate six times that attained by regular chemotherapy. But, that only happened if doctors used genetic information to ...

Onivyde Approved for Advanced Pancreatic Cancer

Posted 27 Oct 2015 by

FRIDAY, Oct. 23, 2015 – The injected drug Onivyde (irinotecan liposome) has been approved by the U.S. Food and Drug Administration for pancreatic cancer that has either spread or is surgically untreatable. Pancreatic cancer is difficult to treat, the agency said, citing U.S. Government estimates that 48,960 new cases would be diagnosed this year and 40,560 would die from it. The new drug's ...

FDA Approves New Pancreatic Cancer Drug Onivyde

Posted 27 Oct 2015 by

THURSDAY, Oct. 22, 2015 – The U.S. Food and Drug Administration has approved a new drug called Onivyde as part of a treatment regimen for advanced pancreatic cancer. Onivyde (irinotecan liposome injection) was approved to be used in combination with fluorouracil and leucovorin. The combination was approved for use in patients with advanced pancreatic cancer who were already treated with ...

FDA Approves Onivyde (irinotecan liposome injection) for Advanced Pancreatic Cancer

Posted 27 Oct 2015 by

October 22, 2015 – The U.S. Food and Drug Administration today approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to treat patients with advanced (metastatic) pancreatic cancer who have been previously treated with gemcitabine-based chemotherapy. According to the National Cancer Institute, there will be 48,960 new cases of pancreatic cancer ...

Ask a Question

Further Information

Related Condition Support Groups

Pancreatic Cancer

Related Drug Support Groups


Irinotecan Liposomal Patient Information at